Enmox Eye Drop contains Moxifloxacin 0.5% w/v, a broad-spectrum fluoroquinolone antibiotic indicated for the treatment of bacterial infections of the eye. Moxifloxacin exerts its antibacterial effect by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication, transcription, repair, and recombination, thereby leading to bacterial cell death. Enmox Eye Drop is primarily prescribed for bacterial conjunctivitis and other superficial ocular infections caused by susceptible strains of Gram-positive and Gram-negative bacteria. The formulation ensures rapid penetration into ocular tissues, providing effective antimicrobial activity with minimal systemic absorption. It is typically administered as one or two drops in the affected eye(s) every 6 to 12 hours, depending on the severity of the infection and clinical response. Patients should adhere strictly to the prescribed dosage and duration to prevent the development of resistance. Common side effects may include mild ocular irritation, burning sensation, or dryness upon instillation, which are generally transient. Enmox Eye Drop is contraindicated in patients with known hypersensitivity to moxifloxacin or other quinolones. Caution is advised in pregnant or lactating women, and use in pediatric populations should be guided by a healthcare professional. Proper hygiene and avoidance of contamination of the dropper tip are essential to maintain sterility.